![Christopher Frankenfield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 14 966 $ in data 31/05/2026
Mr. Christopher Frankenfield is a Chief Operating & Financial Officer at Xilio Therapeutics, Inc. Mr. Frankenfield was previously employed as a Vice President-Corporate & Legal Affairs by Blueprint Medicines Corp.
and a Senior Associate by Wilmer Cutler Pickering Hale & Dorr LLP.
He received his undergraduate degree from The College of William & Mary and a graduate degree from the University of Virginia School of Law.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 02/01/2026 | 1.769 ( 0,03% ) | 14 966 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Direttore Finanziario/CFO | 08/08/2024 |
| Società | Posizione | Fine |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Consigliere Generale | 01/03/2021 |
Wilmer Cutler Pickering Hale & Dorr LLP
 Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
University of Virginia School of Law
 University of Virginia School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
